Kure Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Buy
2,353
+13
+0.6% +$1.25K 0.11% 54
2025
Q4
$225K Buy
+2,340
New +$227K 0.13% 51
2025
Q2
Sell
-5,944
Closed -$534K 47
2025
Q1
$534K Buy
+5,944
New +$532K 0.4% 24
2024
Q3
$839K Sell
9,322
-35
-0.4% -$2.94K 0.75% 18
2024
Q2
$736K Buy
9,357
+32
+0.3% +$2.62K 0.6% 21
2024
Q1
$813K Sell
9,325
-908
-9% -$77.5K 0.69% 18
2023
Q4
$843K Sell
10,233
-193
-2% -$14.7K 0.44% 36
2023
Q3
$817K Buy
+10,426
New +$873K 0.46% 38

Other funds holding MDT

Kure Advisory's MDT Position: Q1 2026 in Review

Kure Advisory increased its Medtronic (MDT) stake by 0.56% in Q1 2026, buying an estimated $1.25K and bringing the position to 2,353 shares worth $204K. The position accounts for 0.11% of the portfolio, ranked #54.

Kure Advisory first reported a position in MDT in Q3 2023 and has held it in 8 quarters since. The position peaked at $843K in Q4 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kure Advisory held 2,353 shares of Medtronic worth $204K as of Q1 2026.
  • Kure Advisory bought 13 Medtronic shares in Q1 2026, an estimated $1.25K.
  • Medtronic made up 0.11% of Kure Advisory's portfolio in Q1 2026, its #54 holding.
  • Kure Advisory first reported a position in Medtronic in Q3 2023 and has held it in 8 quarters since.
  • Kure Advisory's Medtronic position peaked at $843K in Q4 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kure Advisory's 13F filing for Q1 2026, filed 17 Apr 2026.